C32H35ClFN7O2
604.1 g/mol
APIWarning
Adagrasib
CAS2326521-71-3
Category
API
Compound Class
Amine
Primary Use
Pharmaceutical Raw Material
Adagrasib is an oral, small-molecule compound that acts as an inhibitor of KRAS, a protein commonly mutated in cancer. It is supplied as an active pharmaceutical ingredient for use in pharmaceutical manufacturing and research.
pharmaceutical raw material for KRAS-targeted therapiesresearch compound for cancer biology studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2326521-71-3
Related Compounds
ReferenceSame Category
Nalbuphine hydrochloride
CAS23277-43-2
pharmaceutical raw material
ReferenceSame Category
Sulfachlorpyridazine sodium
CAS23282-55-5
pharmaceutical raw material
ReferenceSame Category
Sodium sulfaclozine
CAS23307-72-4
pharmaceutical raw material
ReferenceSame Category
Spectinomycin sulfate
CAS23312-56-3
pharmaceutical raw material
Safety Reference
Warning
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name
2-[(2S)-4-[7-(8-chloronaphthalen-1-yl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile
InChIKey
PEMUGDMSUDYLHU-ZEQRLZLVSA-N
SMILES
CN1CCC[C@H]1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN([C@H](C6)CC#N)C(=O)C(=C)F
Synonyms (15)
- KRAZATI
- Adagrasib (USAN/INN)
- Adagrasib
- Adagrasib (MRTX849)
- Kras G12C inhibitor MRTX849
- Krazati (TN)
- MRTX 849
- MRTX849(Adagrasib)?